[
  {
    "ts": null,
    "headline": "Labcorp Holdings (LH) Unveils Test Finder: AI Tool for Streamlined Lab Test Selection",
    "summary": "Labcorp Holdings (LH) made significant advancements with the launch of its Test Finder tool, developed in collaboration with Amazon Web Services, aimed at enhancing lab test selection for healthcare providers. This innovation, alongside other recent achievements such as the CE-Mark for PGDx elio™ tissue complete and the launch of new health solutions, likely contributed to the company's 9% price increase last quarter. While the broader market experienced positive momentum, supported by strong...",
    "url": "https://finnhub.io/api/news?id=cb5a401e86f45bf2bd4a5c46fe3d67cae527ca9aee9ae7dd89bcc7041d0ae110",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753982512,
      "headline": "Labcorp Holdings (LH) Unveils Test Finder: AI Tool for Streamlined Lab Test Selection",
      "id": 136161539,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp Holdings (LH) made significant advancements with the launch of its Test Finder tool, developed in collaboration with Amazon Web Services, aimed at enhancing lab test selection for healthcare providers. This innovation, alongside other recent achievements such as the CE-Mark for PGDx elio™ tissue complete and the launch of new health solutions, likely contributed to the company's 9% price increase last quarter. While the broader market experienced positive momentum, supported by strong...",
      "url": "https://finnhub.io/api/news?id=cb5a401e86f45bf2bd4a5c46fe3d67cae527ca9aee9ae7dd89bcc7041d0ae110"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp Holdings Inc. stock outperforms competitors despite losses on the day",
    "summary": "Labcorp Holdings Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=158dba33fb866c985474a9a80c64e3342479b14e34c15c73393070ae28677d28",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753981560,
      "headline": "Labcorp Holdings Inc. stock outperforms competitors despite losses on the day",
      "id": 136229382,
      "image": "",
      "related": "LH",
      "source": "MarketWatch",
      "summary": "Labcorp Holdings Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=158dba33fb866c985474a9a80c64e3342479b14e34c15c73393070ae28677d28"
    }
  },
  {
    "ts": null,
    "headline": "Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=7090b3ff1d426ace402210cef57e290fe232c80ba3ee0eb56e290b522cbd9a79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753969802,
      "headline": "Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term",
      "id": 136155579,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=7090b3ff1d426ace402210cef57e290fe232c80ba3ee0eb56e290b522cbd9a79"
    }
  },
  {
    "ts": null,
    "headline": "The 5 Most Interesting Analyst Questions From Labcorp’s Q2 Earnings Call",
    "summary": "Labcorp’s second quarter was marked by broad-based revenue growth and improved profitability, prompting a strong positive market reaction. Management attributed this momentum to robust organic growth in its Diagnostics Laboratory segment, supported by recent acquisitions and expanding partnerships with hospitals and regional labs. CEO Adam Schechter noted that specialty testing areas—such as oncology, women’s health, and neurology—continue to outpace the broader market, helping drive both volume",
    "url": "https://finnhub.io/api/news?id=3516a350ef87cb387eebd6aab03e1b29531ebb08db38c502895d1aece9aa6960",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753939925,
      "headline": "The 5 Most Interesting Analyst Questions From Labcorp’s Q2 Earnings Call",
      "id": 136161540,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp’s second quarter was marked by broad-based revenue growth and improved profitability, prompting a strong positive market reaction. Management attributed this momentum to robust organic growth in its Diagnostics Laboratory segment, supported by recent acquisitions and expanding partnerships with hospitals and regional labs. CEO Adam Schechter noted that specialty testing areas—such as oncology, women’s health, and neurology—continue to outpace the broader market, helping drive both volume",
      "url": "https://finnhub.io/api/news?id=3516a350ef87cb387eebd6aab03e1b29531ebb08db38c502895d1aece9aa6960"
    }
  }
]